IL12 in Candida albicans infections
- 31 October 1995
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 146 (7-8), 532-538
- https://doi.org/10.1016/0923-2494(96)83028-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Interleukin‐4 and ‐10 exacerbate candidiasis in miceEuropean Journal of Immunology, 1995
- Interleukin‐12 production by human polymorphonuclear leukocytesEuropean Journal of Immunology, 1995
- Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites.The Journal of Experimental Medicine, 1994
- Lymphokine Production by Human T Cells in Disease StatesAnnual Review of Immunology, 1994
- T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin‐12 and interferon‐γ and is inhibited by transforming growth factor‐βEuropean Journal of Immunology, 1994
- Interleukin‐12 but not interferon‐γ production correlates with induction of T helper type‐1 phenotype in murine candidiasisEuropean Journal of Immunology, 1994
- Differential effects of interleukin‐12 on the development of naive mouse CD4+ T cellsEuropean Journal of Immunology, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.The Journal of Experimental Medicine, 1992
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989